Literature DB >> 8888711

Fibrolamellar hepatocellular carcinoma. Case reports and a review of the literature.

S Saab1, F Yao.   

Abstract

Fibrolamellar hepatocellular carcinoma is an uncommon malignancy seen in young adults without underlying liver disease. Physical signs are minimal and laboratory values are noncontributory. Diagnosis is suggested by clinical history, supported by radiographic studies, and confirmed by histologic examination. Individuals with fibrolamellar carcinoma generally have a greater survival than those with hepatocellular carcinoma. Although most patients with fibrolamellar carcinoma undergo curative surgery, two of the three patients we report had inoperable tumors.

Entities:  

Mesh:

Year:  1996        PMID: 8888711     DOI: 10.1007/bf02093600

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  38 in total

1.  Gynecomastia as a presenting sign of fibrolamellar carcinoma of the liver.

Authors:  J J McCloskey; E L Germain-Lee; J A Perman; L P Plotnick; A H Janoski
Journal:  Pediatrics       Date:  1988-09       Impact factor: 7.124

2.  Fibrolamellar hepatocarcinoma: radiology, management, and pathology.

Authors:  L K Wong; D P Link; C F Frey; R H Ruebner; H Tesluk; N R Pimstone
Journal:  AJR Am J Roentgenol       Date:  1982-07       Impact factor: 3.959

3.  Fibrolamellar hepatoma.

Authors:  D M Nagorney; M A Adson; L H Weiland; C D Knight; S R Smalley; A R Zinsmeister
Journal:  Am J Surg       Date:  1985-01       Impact factor: 2.565

Review 4.  Fibrolamellar hepatoma.

Authors:  M T Ruffin
Journal:  Am J Gastroenterol       Date:  1990-05       Impact factor: 10.864

5.  Primary hepatic malignancy: the role of liver transplantation.

Authors:  T Ismail; L Angrisani; B K Gunson; S G Hübscher; J A Buckels; J M Neuberger; E Elias; P McMaster
Journal:  Br J Surg       Date:  1990-09       Impact factor: 6.939

6.  Recurrent obstructive jaundice caused by fibrolamellar hepatocellular carcinoma.

Authors:  J S Albaugh; E B Keeffe; W W Krippaehne
Journal:  Dig Dis Sci       Date:  1984-08       Impact factor: 3.199

7.  The histopathologic and clinical indicators of prognosis in hepatoma.

Authors:  J J Chuong; E M Livstone; K W Barwick
Journal:  J Clin Gastroenterol       Date:  1982-12       Impact factor: 3.062

8.  Neurotensin secretion by fibrolamellar carcinoma of the liver.

Authors:  N A Collier; K Weinbren; S R Bloom; Y C Lee; H J Hodgson; L H Blumgart
Journal:  Lancet       Date:  1984-03-10       Impact factor: 79.321

9.  Case report. Hepatocellular carcinoma with lamellar fibrosis: an important histological variant.

Authors:  L J Slavutin; N Diamond
Journal:  Pathology       Date:  1981-10       Impact factor: 5.306

10.  Hepatocellular carcinoma in young people.

Authors:  D C Farhi; R H Shikes; P J Murari; S G Silverberg
Journal:  Cancer       Date:  1983-10-15       Impact factor: 6.860

View more
  4 in total

1.  Epidemiology of primary and secondary liver cancers.

Authors:  Ashwin Ananthakrishnan; Veena Gogineni; Kia Saeian
Journal:  Semin Intervent Radiol       Date:  2006-03       Impact factor: 1.513

2.  Fibrolamellar hepatocellular carcinoma in mexican patients.

Authors:  Julian Arista-Nasr; Lisa Gutierrez-Villalobos; Juan Nuncio; Hector Maldonaldo; Leticia Bornstein-Quevedo
Journal:  Pathol Oncol Res       Date:  2002       Impact factor: 3.201

Review 3.  Fibrolamellar carcinoma: 2012 update.

Authors:  Michael Torbenson
Journal:  Scientifica (Cairo)       Date:  2012-09-23

4.  Clinical features and surgical outcomes of fibrolamellar hepatocellular carcinoma: retrospective analysis of a single-center experience.

Authors:  Anastasia Lemekhova; Daniel Hornuss; Georgios Polychronidis; Philipp Mayer; Christian Rupp; Thomas Longerich; Karl-Heinz Weiss; Markus Büchler; Arianeb Mehrabi; Katrin Hoffmann
Journal:  World J Surg Oncol       Date:  2020-05-12       Impact factor: 2.754

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.